The future of biomedical innovation depends in part on a new trend for all players in biomedical innovation to work together for the common goal, say 2 MIT researchers
It’s a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.
An essential new way to move discoveries forward has emerged in the form of multi-stakeholder collaborations involving three or more different types of organizations, such as drug companies, government regulators and patient groups, write Magdalini Papadaki, a research associate, and Gigi Hirsch, a physician-entrepreneur and executive director of the MIT Center for Biomedical Innovation.
The authors are calling for a new “science of collaboration” to learn what works and doesn’t work; to improve how leaders can design, manage and evaluate collaborations; and to help educate and train future leaders with the necessary organizational and managerial skills.
“Getting new, better, affordable drugs to the right patients faster involves a series of historically independent decisions made by different players or stakeholders,” says Hirsch. The system is uncoordinated, takes too long, and costs too much. In some cases, the drug—such as new antibiotics for life-threatening resistant infections—may never become available.
“One of the interesting paradoxes of biomedical innovation is increasingly going to be that even though we have the scientific knowledge required to provide potentially better treatments for patients—or even to prevent disease in those who are at high risk—we may be unable to help patients benefit from them anytime soon,” she says.
To help change this scenario, in the last decade, thousands of researchers, pharmaceutical and biotechnology companies, government regulators, payers, clinicians and patients have come together in more than 100 multi-stakeholder collaborations to solve some specific shared problem standing in the way of finding a cure or a better diagnostic approach.
“Multi-stakeholder collaborations provide the opportunity to create an environment that allows for new kinds of interactions among the players,” Hirsch says. The largest multi-stakeholder effort, the European Union’s Innovative Medicines Initiative (IMI) began in 2008 and has established more than 40 consortia with financial and in-kind investments totaling €2 billion. Some projects focus on specific health issues, such as Alzheimer’s disease, chronic pain, diabetes and obesity. Others tackle bigger issues, such as drug and vaccine safety and the use of stem cells for drug discovery. The success has led to a proposal to extend the effort for 10 years and €3.5 billion. Last year, the U.S. President’s Council of Advisors on Science and Technology (PCAST) recommended the U.S. form something similar.
“The prevalence of multi-stakeholder initiatives reflects a continued optimism about the value of this collaboration approach for addressing biomedical innovation bottlenecks,” the authors write in the paper. “Although the need for collaboration is no longer in question, it is worth noting the importance of this development. A willingness to share proprietary data among industry competitors represents a dramatic shift in the culture of the historically highly competitive pharmaceutical industry.”
The article reviews the history of collaborations beginning with HIV/AIDS. By the early 2000s, multi-stakeholder collaborations proliferated to address the need for important tools, such as biomarkers, that require preclinical data sharing. Since then, they have reached to encompass later stages in product development, including manufacturing, reimbursement and post-market monitoring.
Some people involved in multi-stakeholder consortia are concerned about redundancy, inefficiency and lack of productivity of some collaborative efforts, all contributing to a sense of “consortium fatigue,” the researchers write.
In a newer trend, funders and participants are seeking a smaller number of strategically coordinated initiatives that will reliably address critical gaps, Hirsch and Papadaki write. They cite the example of TransCelerate BioPharma, a group of 10 major pharmaceutical companies that came together to share and direct resources toward selected priorities in order to improve the efficiency of drug development, such as clinical trial site qualification standards.
The authors propose a rigorous evidence-based approach (the science of collaboration) to figure out what works and doesn’t work in collaborations. They recommend early steps in this new field and structuring the research to help learn from the past but also to evolve effectively as new innovation challenges emerge.
The Latest Bing News on:
Science of collaboration
- NASA’s Global View of COVID-19 Impacts (2 Videos)on June 29, 2020 at 6:35 pm
NASA, ESA and JAXA unveiled a dashboard of satellite data showing impacts on the environment and socio-economic activity caused by the global response to the coronavirus (COVID-19) pandemic.
- Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assayon June 29, 2020 at 5:26 pm
Ten leading U.S. medical institutions are engaging in the study, sponsored by the National Institutes of Health (NIH) and entitled Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC).
- Colombian Ambassador: Nearshoring, Trade Collaboration Could ‘Make the Americas Great Again’on June 29, 2020 at 4:15 pm
As U.S. firms rethink their global supply chains in the wake of COVID-19, using Colombia as a production base could be part of an effort to “make the Americas great again,” the country’s ambassador ...
- New study shows how tests of hearing can reveal HIV's effects on the brainon June 29, 2020 at 1:15 pm
Findings from a new study published in Clinical Neurophysiology, involving a collaborative effort between Dartmouth's Geisel School of Medicine and the Auditory Neuroscience Laboratory at Northwestern ...
- Phillip Martin Wins 2020 PMJA Award for Best Collaborative Efforton June 29, 2020 at 1:07 pm
Pulitzer Center grantee Phillip Martin was honored for his WGBH collaboration exploring caste discrimination in the United States.
- Toward Principles of Gene Regulation in Multicellular Systemson June 29, 2020 at 12:55 pm
Quantitative biologists from Northwestern combine precision measurements and mathematical models to uncover a common mechanism regulating gene expression during development.
- Computing collaboration reveals global ripple effect of shifting monsoonson June 29, 2020 at 10:00 am
Scientists from the Department of Energy's Oak Ridge National Laboratory and a dozen other international research institutions have produced the most elaborate set of projections to date that ...
- Collaborative Data Science Company Cape Privacy Secures $5 Millionon June 28, 2020 at 11:12 pm
Cape Privacy — a privacy platform for collaborative data science and machine learning — announced that it raised $5 million in seed funding.
- Burning Rock and CStone Pharmaceuticals reached a strategic collaboration on the co-development of companion diagnostics for pralsetinib in Chinaon June 28, 2020 at 6:23 pm
On June 29, 2020, Burning Rock Biotech Limited (NASDAQ: BNR) announced a strategic partnership with CStone Pharmaceuticals (HKEX: 2616) to co-develop and commercialize companion diagnostics (CDx) for ...
- Access a Global View of COVID-19 Impacts Produced by an Unprecedented Collaboration of Space Agencieson June 28, 2020 at 2:25 pm
In an unprecedented collaboration, ESA, NASA and JAXA (Japan Aerospace Exploration Agency) have created a new tool that combines a wealth of data from Earth-observing satellites to monitor the ...
The Latest Google Headlines on:
Science of collaboration
The Latest Bing News on:
- Of Mice and Humanon June 29, 2020 at 6:42 pm
A newly constructed mouse model better predicts human responses to nerve agents and their medical countermeasures. The use of mice and other small animals, referred to as animal models, is common in ...
- Drexel Takes Top Spot on National Rankings for Innovationon June 26, 2020 at 11:49 am
Bush Institute and Opus Faveo Innovation Development recently named Drexel University the most innovative mid-sized research university in the country. These two organizations — the former an offshoot ...
- Best in Tech 2020: Damini Agarwal, Infinite Biomedical Technologieson June 26, 2020 at 5:00 am
Damini Agarwal has worked on life-changing technologies, including developing interfaces for prosthetics, with Infinite Biomedical Technologies here in Baltimore.
- Aether Biomedical secured funding from Chiratae Ventureson June 24, 2020 at 3:23 am
Chiratae Ventures has now revealed that it has invested an undisclosed amount in the Aether Biomedical, a medical robotics startup ...
- Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragranceon June 24, 2020 at 12:42 am
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that they proved in vitro success of Equivir and 3F ...
- Chiratae Ventures invests in medical robotics startup Aether Biomedicalon June 23, 2020 at 10:33 pm
The company said the funding will primarily be used for commercialization of Zeus, a multi-functional hand bionic prosthesis, across India and Europe.It also aims to continue its research and developm ...
- Qatar- Singapore plans more than $14bn to super-charge innovationon June 20, 2020 at 3:48 pm
Singapore is positioning itself for a post-Covid world with massive investment in innovation, over and above the immediate support it's giving to help the economy rebound from possibly its worst ...
- Singapore plans more than $14bn to super-charge innovationon June 20, 2020 at 8:24 am
Covid world with massive investment in innovation, over and above the immediate support it’s giving to help the economy rebound from possibly its worst downturn on record.
- Singapore Plans More Than $14 Billion to Super-Charge Innovationon June 20, 2020 at 5:36 am
Follow Bloomberg on LINE messenger for all the business news and analysis you need.Singapore is positioning itself for a post-Covid world with massive investment in innovation, over and above the imme ...
- Behind the scenes of exciting biochemical engineering innovation in the USon June 17, 2020 at 1:25 am
In the School of Chemical, Materials and Biomedical Engineering at the University of Georgia (UGA), biochemical engineering research is driven by ...